Schwarz Neupro Parkinson’s Patch Is Firm’s First Attempt At New Drug Market

Generic firm announces submission of U.S. and EU applications for novel Parkinson’s disease product. NDA is based on studies in early-stage PD. NDA for late-stage PD is expected in first quarter 2006, partner Aderis says.